Introduction The landscape of biologics in Bulgaria is evolving rapidly, creating an urgent need for a robust framework for post-market safety monitoring. This essential process not only guarantees th...
<h2 id="introduction">Introduction</h2> <p>The landscape of biologics in Bulgaria is evolving rapidly, creating an urgent need for a robust framework for post-market safety monitoring. This essential process not only guarantees the ongoing effectiveness and safety of biological products but also plays a crucial role in protecting public health and fostering trust in these therapies. However, the integration of diverse data sources and the adaptation to changing regulatory requirements pose significant challenges. How can organizations effectively navigate these hurdles to enhance safety monitoring practices and ultimately improve patient outcomes?</p> <p>Addressing these challenges requires a strategic approach that leverages data and collaboration. By establishing a comprehensive safety monitoring system, stakeholders can ensure that biological products remain safe and effective throughout their lifecycle. This proactive stance not only mitigat…